A Detroit Lions mailbag published on January 28, 2026, addressed growing fan concerns and rumors surrounding the health of safety Kerby Joseph and the timing of his recent contract extension. The key revelation was that the Lions’ front office, led by General Manager Brad Holmes, was not aware of a potential knee injury to Joseph at the time they signed him to a new long-term deal. This clarification comes amidst scrutiny of the investment in a player with a recent injury history.
Joseph, 25, is a core member of the Lions’ secondary but dealt with knee problems during the 2025 season. He suffered a bone bruise in Week 4 that sidelined him and had previously managed knee issues during training camp. Despite this, the Lions proceeded with a significant commitment, reportedly a four-year extension worth $85 million with over $36 million guaranteed. The mailbag insight suggests the team viewed these as unrelated, in-season injuries rather than a pre-existing condition that should have affected the contract negotiation. This situation highlights the inherent risk in NFL contracts and the medical evaluations that precede them.
The debate now centers on Joseph’s long-term durability and the Lions’ risk management. When healthy, Joseph is a ball-hawking safety who has proven to be a playmaker. However, investing top-tier safety money in a player with knee concerns is a calculated gamble. The Lions’ defense, which showed improvement in 2025, relies on Joseph’s range and instincts on the back end. His ability to stay on the field in 2026 will be critical not only for the defense’s performance but also for justifying the front office’s decision. This episode underscores the complex interplay between player evaluation, medical assessments, and salary cap management during a critical offseason where the Lions are weighing several major extensions for their young stars.